Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical TrialCorrado Tinterri, Anna Cariello, Francesco Caruso et al.|Annals of Surgical Oncology|2022Cited by 162
Sentinel lymph node biopsy <i>versus</i> axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolmentCorrado Tinterri, Emanuele Zarba Meli, Giuseppe Canavese et al.|British journal of surgery|2023Cited by 63
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma PatientsUmberto Cariboni, Marco Alloisio, Rita De Sanctis et al.|American Journal of Clinical Oncology|2018Cited by 31
The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer.A.M.M. Eggermont, D. J. Ruiter, Ulrich Keilholz et al.|PubMed|2001Cited by 18
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practiceAgnese Losurdo, Armando Santoro, Rita De Sanctis et al.|Scientific Reports|2020Cited by 15